Amanote Research
Register
Sign In
Analysis of the Off-Licence Use of Recombinant Activated Factor VII for Patients With Uncontrolled Haemorrhage in a UK Tertiary Referral Hospital
Critical Care
- United Kingdom
doi 10.1186/cc7596
Full Text
Open PDF
Abstract
Available in
full text
Categories
Critical Care
Intensive Care Medicine
Date
January 1, 2009
Authors
M Spivey
H Eve
M Duffy
Publisher
Springer Science and Business Media LLC
Related search
Successful Use of Recombinant Activated Factor VII for Postoperative Associated Haemorrhage: A Case Report
Cases Journal
Potential Thrombogenic Complications With the Use of Recombinant Activated Factor VII in Combat Trauma
Clinical and Applied Thrombosis/Hemostasis
Medicine
Hematology
Intraoperative Use of Recombinant Activated Factor VII During Complex Aortic Surgery
Journal of Thoracic and Cardiovascular Surgery
Respiratory Medicine
Pulmonary
Cardiovascular Medicine
Surgery
Cardiology
The Use of Recombinant Activated Factor VII for Refractory Bleeding Post Complex Cardiothoracic Surgery
Anaesthesia and Intensive Care
Critical Care
Anesthesiology
Pain Medicine
Intensive Care Medicine
Administration of Recombinant Activated Factor VII (NovoSeven) in Three Cases of Uncontrolled Bleeding Caused by Disseminated Intravascular Coagulopathy
Clinical and Applied Thrombosis/Hemostasis
Medicine
Hematology
Preemptive Use of Recombinant Activated Factor VII: Many Questions but Few Answers
Canadian Journal of Anaesthesia
Medicine
Anesthesiology
Pain Medicine
Recombinant Activated Factor VII and Aortic Surgery
European Journal of Vascular and Endovascular Surgery
Surgery
Cardiovascular Medicine
Cardiology
Recombinant Activated Factor VII (rFVIIa) Treatment of Refractory Bleeding in Cardiac Surgical Patients
Journal of Anesthesia & Clinical Research
Use of Recombinant Factor VII in Cardiac Surgery
Recent Patents on Cardiovascular Drug Discovery
